
On August 30, 2024, the Biopharmaceuticals Advanced Technology Seminar · was jointly organized by the Truking Technology and Suzhou Biopharmaceuticals industry alliance. The station was successfully held at the Suzhou InterContinental Hotel on Jinji Lake. The meeting was attended by more than 200 guests, including relevant executives of nearly one hundred biopharmaceutical companies from Jiangsu, Zhejiang, Shanghai and other regions. During the conference, guests enthusiastically discussed the “opportunities and challenges” of the biopharmaceutical industry in the face of economic fluctuations. A number of technical experts from Truking Technology spoke at the meeting and discussed with industry guests the latest technologies and development trends in the field of biopharmaceuticals, and exchanged views and discussed how to apply advanced technologies to solve problems and seize opportunities to promote industrial development.
Relevant persons in charge of nearly one hundred biopharmaceutical companies in the regions of Jiangsu, Zhejiang and Shanghai.
In total, more than 200 people attended the meeting
The Third Plenum of the 20th CPC Central Committee held in July this year noted that it is necessary to improve policies and management systems to promote the development of strategic industries such as high-quality equipment manufacturing and biopharmaceuticals, and guide the healthy and orderly development of new industries. Suzhou is an important city in China's biopharmaceutical industry, ranking first in the country. “Biopharma is an emerging strategic industry that faces enormous opportunities as well as challenges. From a macroeconomic point of view, China's biopharmaceutical economy has achieved tremendous development, and the industrial scale continues to expand." Li Junning, Chairman of Suzhou Biopharmaceuticals Industry Alliance and founder and chairman of Lisheng Pharmaceutical (Suzhou) Co., Ltd., attended the 2024Biopharmaceuticals Advanced Technology Research and Development Exhibition. In a speech on the Forum·Suzhou website, he said that China's biopharmaceutical economy has moved step by step from the early "version 1.0" - a "low industry" compared to foreign technologies - to today's version "2.0", "We have our own research and understanding of scientific principles, the research and development of key technologies, and the transformation and application of innovative technologies. These are powerful engines driving the rapid development of China's biopharmaceuticals industry."

Truking Technology is a leading enterprise in the China biopharmaceutical equipment industry. “He played a very huge role in the economic development process of China biopharmaceuticals. He even leads. has taken many measures to meet the needs of the life sciences industry and has developed very rich and advanced pharmaceutical manufacturing technologies and solutions. It also brings together a group of advanced technology companies and has the biopharmaceuticals and ancillary advanced processing technologies needed in life. This is all for us. biopharmaceuticals and the development of the life sciences industry have become a huge driving force,” said Li Junning. “When the economic environment reaches a period of uncertainty, our industry needs more of the 'three hugs' - staying together to stay warm, growing together and traveling abroad together, so we are thrilled to join forces with Truking Technology to host this event.”

Suzhou Biopharmaceuticals Industry Alliance PresidentFounder and Chairman of Lisheng Pharmaceutical (Suzhou) Co., Ltd.Dr. Li Junning gave a speech at the event
Lei Yu, President of Domestic Sales of Truking Technology, gave a speech at the event on behalf of Truking Technology, saying: “As Dr. Li Junning pointed out, the current China biopharmaceuticals industry faces both challenges and opportunities. In July this year, the State Council reviewed and approved the Full Chain Implementation Plan to support the development of innovative technologies. Medicines" means that the entire support chain of innovative drugs, from review and approval, access, use to capital support, especially international prices of innovative drugs and costs beyond basic health insurance, will soon become a reality, and the China biopharmaceutical industry will embark on a new path of innovation. “Suzhou is one of the important markets for Truking Technology in East China. “We firmly believe that the entire market, including the Suzhou biopharmaceuticals field, will have a stronger development trend and broader development prospects in the future. We are at ZX"

Truking Technology event website

Truking Technology forum activity
After more than 20 years of development, Truking Technology has become a first-class medical equipment enterprise in the world. Truking Technology has attached great importance to research, development and innovation for many years, and is committed to providing intelligent solutions and services to pharmaceutical companies. Especially in recent years, it has made great strides in the field of general bioengineering technology solutions, overcome a number of stuck technologies, and played an important role in promoting domestic import substitution. A number of technical experts from Central Technology Research Institute Truking Technology and its subsidiaries Truking Ingenuity, Chutian Huatong, Sichuan Institute of Pharmaceutical Design and other companies gave a series of speeches on advanced technologies in key areas of the Biopharmaceuticals Division and held in-depth discussions with guests. Chen Hengshan, Senior Vice President of Truking Technology and Vice President of Central Institute of Technology, gave his first speech on the topic of "Innovative Drug Delivery Technologies and Solutions", detailing Truking Technology's innovative achievements in new drug delivery technologies in recent years, in addition to classic liquid drug subfilling solutions, and the resulting overall solution that can satisfy users from laboratory to mass production.

Truking Technology Senior Vice President and Vice President of Central Research Institute of Technology Chen HengshanHe gave a presentation on the topic “Innovative technologies and solutions for drug delivery.”
The revised version of the PIC/S and GMP Sterile Drug Annex is significantly updated and differs from the ChinaGMP Sterile Drug Annex in terms of concepts and other aspects reflecting international drug regulatory standards. The improvement will have a long-term impact on China's regulations and standards, as well as pharmaceutical companies. This will help promote the integration of China standards with international standards and improve the overall level of China's sterile pharmaceutical manufacturing industry. Zheng Qiping, Chief Pharmaceutical Technology Expert of Central Institute of Technology Truking Technology, gave a special speech at the meeting on "Comparative Research and Analysis of Sterile Drug Manufacturing in PIC/S and GMP Application", in-depth analysis of the key points of improving regulatory standards and the potential impact on China pharmaceutical companies provides reference ideas for China drug sterility testing and international integration, especially new ideas for China pharmaceutical companies to understand international regulations and standards, quality standards and international standards. Zheng Qiping's thorough analysis aroused great interest and resonance among those present. They took out their mobile phones to record the details of the analysis in speech. After the speech, discussions and exchanges of views began on many exciting issues.

Truking Technology Central Technology Research InstituteChief Pharmaceutical Technology Expert Zheng Qiping Delivers a Speech
Truking Technology technical experts Cheng Wei and Chen Chen respectively gave presentations on the application and discussion of isolator technology in pharmaceutical manufacturing and general solutions for commercial plasmid DNA production. Technical experts gave presentations focusing on separation and purification process equipment and improving production efficiency, risk control in pharmaceutical water systems, EPC applications in pharmaceutical engineering and biotech centrifuge applications, presenting innovative concepts, technologies and solutions from Truking Technology and its subsidiaries in the biopharmaceuticals field. The event also showcased the ultrafiltration chromatography system, uniform flow pump, hollow fiber ultrafiltration column and other innovative equipment and key components of Truking Technology and its subsidiaries, providing participants with an intuitive experience of the achievements of advanced technologies. 2024Biopharmaceuticals Advanced Technology Workshop · Suzhou Station has created a platform for industry exchange and cooperation. “The collision of ideas and the combination of wisdom can inspire new inspiration and open new horizons,” giving new impetus to the advancement of technological innovation and industrial development of biopharmaceuticals.






Truking Technology Many technical experts gave speechesand held in-depth discussions and exchanges with guests



Various innovative Truking Technology devices attracted a lot of attention from conference guests.





